Experts from the life science and research community explain the crucial role of intellectual property rights in developing new vaccines and therapeutics for Covid-19.
The WHO has a crucial role in coordinating the global response to pandemics and health emergencies, but this important work is undermined by strategic incoherence and an ideological approach to policymaking.
Geneva Network and allied think tanks have written to the European Commission calling for innovation to be at the heart of its Pharmaceutical Strategy.
The patent system in the US and the EU is not rewarding complex research into treatments for a host of prevalent diseases and conditions, and reforms are going in the wrong direction, says Erika Lietzan of the University of Missouri School of Law.
Traditional rivals within the life sciences industry have pledged to cooperate by sharing data, patent libraries, and, if necessary, manufacturing capacity.
We are an international coalition of public policy research institutes and think tanks that believes that the collaboration, open trade and innovation will provide the solutions to the COVID-19 crisis.
They say bullying scars for life, but for one Saudi medical specialist it was early inspiration for a ground-breaking innovation at the sharp end of cartilage reconstruction.
With around a third of the world’s population in lockdown, humanity desperately needs new treatments to turn the tide against COVID-19.
Despite the important role of intellectual property rights in incentivizing innovation, the patenting of pharmaceutical innovation is frequently accused of impeding access to medicine.